Alimera Sciences Europe Limited

Ophthalmology

Clinical research is centred on eye disease, with a focus on non-infectious uveitis affecting the posterior segment of the eye. The sponsor’s activity in this area reflects interest in inflammatory conditions that can threaten visual function.

  • Posterior segment uveitis
  • Inflammatory eye disorders
  • Paediatric ophthalmic disease

The research landscape includes care for children with recurrent ocular inflammation and conditions requiring specialised management within the retina and vitreous region.

Paediatric Medicine

Trial activity includes children’s health, with attention to paediatric patients living with chronic inflammatory eye disease. This places the sponsor within therapeutic areas that address unmet needs in younger populations.

  • Paediatric uveitis
  • Recurrent inflammatory disease
  • Specialist paediatric care

Research interest extends to clinical management of recurrent disease in children, where preserving vision is a key concern.

Inflammation and Immune-Mediated Disease

The sponsor’s therapeutic focus includes non-infectious inflammatory conditions of the eye, indicating involvement in disease areas driven by immune-mediated processes rather than infection.

  • Immune-mediated ocular inflammation
  • Chronic inflammatory disease
  • Non-infectious pathology

This area of research is relevant to conditions where controlling inflammation is central to protecting ocular structures and function.

Specialist Eye Therapeutics

Clinical research includes implant-based ocular therapy for disease affecting the posterior eye, showing interest in targeted treatment approaches within specialist ophthalmic practice.

  • Ocular implant therapy
  • Localised eye treatment
  • Retinal region disease management

The sponsor’s portfolio is directed toward therapies used in specialised eye care settings for persistent inflammatory disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of Fluocinolone Acetonide Implant for Children Aged 6-17 with Recurrent Non-Infectious Uveitis in the Eye’s Posterior Segment

    Recruiting

    1 1 1 1
    Germany Spain